Heart Failure
Definition
• structural or functional CD
• impairs the blood filling/ejecting ability
of ventricles
• inability to maintain the metabolic needs
of the body
Causes
Heart performance (CO)
depends on:
• Contractility
• Preload
• Afterload
• Heart Rate
Causes:
• Abnormal loading conditions
• Abnormal muscle function
• Conditions that limit
ventricular filling
 Congenital defects
 Valvular heart diseases
 Septal defects
 Hypertension
 Myocardial infarction
 Myocarditis
 Cardiomyopathy
 Alcoholism
 Mitral or tricuspid stenosis
 Pericarditis
 Ischaemic heart disease
 Drugs
 Thyrotoxicosis
CO = SV x HR
Classifications
Backward Failure Forward Failure
High Output
Low Output
RSHF LSHF
Acute vs. Chronic
Acute
• Develops rapidly
• Can be immediately life
threatening
• Dramatic drop in cardiac
output
• May be new (e.g. acute MI,
sepsis) or an exacerbation
of chronic disease
Chronic
• Long term
• More insidious
• Associated with the heart
undergoing adaptive
responses (e.g. dilation,
hypetrophy) to a
precipitating cause
Symptoms
• Fatigue
• Activity decrease
• Cough (especially supine)
• Edema
• Shortness of breath
Symptoms
RVF
– Fatigue
– Weakness
– Lethargy
– Weight gain
– Anorexia
– RUQ pain
– Hepatomegaly
– Neck vein pulsations
– Jugular veinous
distension
– Pitting edema
LVF
– Fatigue
– Anxiety
– Insomnia
– Tachycardia
– Gallop heart sounds (S3,
S4)
– Pulmonary crackles,
rales
– Orthopnea PND
– Cheyne Stokes
– Cough
Pathophysiology
Compensatory mechanism:
1. Hemodynamic alterations
2. Neurohormonal responses (SNS, RAAS,
Vasopressin)
3. Ventricular dilation
4. Ventricular hypertrophy
Response Short-Term
Effects
Long-Term
Effects
Salt and Water Retention Augments preload Pulmonary Congestion,
Anasarca
Vasoconstriction Maintains BP for perfusion
of vital organs
Exacerbates pump
dysfunction (excessive
afterload), increases
cardiac energy
expenditure
Simpathetic stimulation Increases HR and ejection Increases energy
expenditure
Frank-Starling Mechanism
• The ability of the heart to change its force of
contraction and therefore stroke volume in
response to changes in venous return.
• In heart failure, there is a compensatory
increase in venous return which is augmented
by neurohormonal mechanisms.
• Due to increase in venous return, there is a
temporary increase in stroke volume.
Diagnostic Studies
• X-ray (Kerley B lines)
• ECG
• Echocardiography (EF)
• Laboratory data (cardiac enzymes, BNP, serum
chemistries ,liver function studies ,thyroid
function studies and complete blood count)
• Stress testing (exercise or medicine)
• Cardiac catheterization- determine heart
pressures ( inc.PAW )
ECG
ECG findings are not diagnostic, but:
• Old MI or recent MI
• Arrhythmia
• Some forms of tachycardia related
cardiomyopathies
• LBBB
Approach to the Patient with HF
• Diagnose
– Etiology
– Severity (LV dysfunction)
• Initiate
– Diuretic/ACE inhibitor
– -blocker
– Spirololactone
– Digoxin
• Educate
– Diet
– Exercise
– Lifestyle
– CV Risk
• Titrate
– Optimize ACE inhibitor
– Optimize -blocker

Heart failure

  • 1.
  • 2.
    Definition • structural orfunctional CD • impairs the blood filling/ejecting ability of ventricles • inability to maintain the metabolic needs of the body
  • 3.
    Causes Heart performance (CO) dependson: • Contractility • Preload • Afterload • Heart Rate Causes: • Abnormal loading conditions • Abnormal muscle function • Conditions that limit ventricular filling  Congenital defects  Valvular heart diseases  Septal defects  Hypertension  Myocardial infarction  Myocarditis  Cardiomyopathy  Alcoholism  Mitral or tricuspid stenosis  Pericarditis  Ischaemic heart disease  Drugs  Thyrotoxicosis CO = SV x HR
  • 4.
    Classifications Backward Failure ForwardFailure High Output Low Output RSHF LSHF
  • 5.
    Acute vs. Chronic Acute •Develops rapidly • Can be immediately life threatening • Dramatic drop in cardiac output • May be new (e.g. acute MI, sepsis) or an exacerbation of chronic disease Chronic • Long term • More insidious • Associated with the heart undergoing adaptive responses (e.g. dilation, hypetrophy) to a precipitating cause
  • 7.
    Symptoms • Fatigue • Activitydecrease • Cough (especially supine) • Edema • Shortness of breath
  • 8.
    Symptoms RVF – Fatigue – Weakness –Lethargy – Weight gain – Anorexia – RUQ pain – Hepatomegaly – Neck vein pulsations – Jugular veinous distension – Pitting edema LVF – Fatigue – Anxiety – Insomnia – Tachycardia – Gallop heart sounds (S3, S4) – Pulmonary crackles, rales – Orthopnea PND – Cheyne Stokes – Cough
  • 9.
    Pathophysiology Compensatory mechanism: 1. Hemodynamicalterations 2. Neurohormonal responses (SNS, RAAS, Vasopressin) 3. Ventricular dilation 4. Ventricular hypertrophy
  • 10.
    Response Short-Term Effects Long-Term Effects Salt andWater Retention Augments preload Pulmonary Congestion, Anasarca Vasoconstriction Maintains BP for perfusion of vital organs Exacerbates pump dysfunction (excessive afterload), increases cardiac energy expenditure Simpathetic stimulation Increases HR and ejection Increases energy expenditure
  • 11.
    Frank-Starling Mechanism • Theability of the heart to change its force of contraction and therefore stroke volume in response to changes in venous return. • In heart failure, there is a compensatory increase in venous return which is augmented by neurohormonal mechanisms. • Due to increase in venous return, there is a temporary increase in stroke volume.
  • 12.
    Diagnostic Studies • X-ray(Kerley B lines) • ECG • Echocardiography (EF) • Laboratory data (cardiac enzymes, BNP, serum chemistries ,liver function studies ,thyroid function studies and complete blood count) • Stress testing (exercise or medicine) • Cardiac catheterization- determine heart pressures ( inc.PAW )
  • 13.
    ECG ECG findings arenot diagnostic, but: • Old MI or recent MI • Arrhythmia • Some forms of tachycardia related cardiomyopathies • LBBB
  • 14.
    Approach to thePatient with HF • Diagnose – Etiology – Severity (LV dysfunction) • Initiate – Diuretic/ACE inhibitor – -blocker – Spirololactone – Digoxin • Educate – Diet – Exercise – Lifestyle – CV Risk • Titrate – Optimize ACE inhibitor – Optimize -blocker